These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
401 related items for PubMed ID: 19578174
21. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ. Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591 [Abstract] [Full Text] [Related]
23. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough? Curtis AB. J Am Coll Cardiol; 2008 Aug 12; 52(7):557-8. PubMed ID: 18687250 [No Abstract] [Full Text] [Related]
25. Sudden death prevention with implantable devices. Passman R, Kadish A. Circulation; 2007 Jul 31; 116(5):561-71. PubMed ID: 17664385 [No Abstract] [Full Text] [Related]
26. Unresolved issues in implantable cardioverter-defibrillator therapy. Mason PK, DiMarco JP. Cardiol Clin; 2008 Aug 31; 26(3):433-9, vii. PubMed ID: 18538189 [Abstract] [Full Text] [Related]
27. Recent advancements in the management of sudden cardiac death: implantable antiarrhythmic devices. Bissett J, Talley JD. J Ark Med Soc; 1995 Jun 31; 92(1):41-3. PubMed ID: 7615479 [No Abstract] [Full Text] [Related]
28. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C. Arch Intern Med; 2009 Sep 14; 169(16):1500-6. PubMed ID: 19752408 [Abstract] [Full Text] [Related]
29. Ventricular tachycardia and ventricular fibrillation. Srivathsan K, Ng DW, Mookadam F. Expert Rev Cardiovasc Ther; 2009 Jul 14; 7(7):801-9. PubMed ID: 19589116 [Abstract] [Full Text] [Related]
30. Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. Braunschweig F, Boriani G, Bauer A, Hatala R, Herrmann-Lingen C, Kautzner J, Pedersen SS, Pehrson S, Ricci R, Schalij MJ. Europace; 2010 Dec 14; 12(12):1673-90. PubMed ID: 20974757 [No Abstract] [Full Text] [Related]
35. Implantable electrical devices for prevention of sudden cardiac death: data on implant rates from a 'real world' regional registry. Boriani G, Berti E, Biffi M, Marino M, Sassone B, Villani GQ, Bottoni N, Malavasi VL, Melandri F, Barbato G, Talamonti E, Marconi M, RERAI (Registry of Emilia Romagna on Arrhythmia Interventions) Investigators. Europace; 2010 Sep 14; 12(9):1224-30. PubMed ID: 20584740 [Abstract] [Full Text] [Related]
36. Electrophysiologic refinement of risk stratification: can we achieve the goal? Israel CW, Hohnloser SH. J Cardiovasc Electrophysiol; 2004 Feb 14; 15(2):177-8. PubMed ID: 15028047 [No Abstract] [Full Text] [Related]
40. [Indications for implantable automatic ventricular defibrillators. A report from the Heart Rhythm Group of the French Society of Cardiology]. Aliot E, Chauvin M, Daubert JC, Frank R, Jondeau G, Leclercq JF, Le Heuzey JY, Heart Rhythm Group of the French Society of Cardiology. Arch Mal Coeur Vaiss; 2006 Feb 10; 99(2):141-54. PubMed ID: 16555698 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]